IGF1 and urinary bladder carcinoma: Finally, using publicly available data from the Cancer Cell Line Encyclopedia (http://www.broadinstitute.org/ccle), we assessed the correlation between mRNA levels for components of the IGF pathway and cell sensitivity (inhibition of cell viability) to a tyrosine kinase inhibitor directed against IGF1R in bladder cancer-derived cell lines.